Moleculin Biotech, Inc. Quarterly Operating Income (Loss) in USD from Q3 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Moleculin Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2015 to Q3 2024.
  • Moleculin Biotech, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$7.14M, a 20% decline year-over-year.
  • Moleculin Biotech, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$28.9M, a 4.16% decline year-over-year.
  • Moleculin Biotech, Inc. annual Operating Income (Loss) for 2023 was -$29.6M, a 3.29% increase from 2022.
  • Moleculin Biotech, Inc. annual Operating Income (Loss) for 2022 was -$30.6M, a 33.4% decline from 2021.
  • Moleculin Biotech, Inc. annual Operating Income (Loss) for 2021 was -$23M, a 16.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$28.9M -$7.14M -$1.19M -20% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$27.7M -$6.19M +$226K +3.53% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$28M -$6.68M +$1.68M +20.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$29.6M -$8.92M -$1.87M -26.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$27.8M -$5.95M +$3.14M +34.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$30.9M -$6.41M +$1.02M +13.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$31.9M -$8.35M -$1.28M -18.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$30.6M -$7.05M -$1.84M -35.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$28.8M -$9.08M -$2.93M -47.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$25.9M -$7.43M -$1.92M -34.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$24M -$7.07M -$986K -16.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$23M -$5.21M -$1.71M -49% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$21.3M -$6.16M -$6K -0.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$21.3M -$5.52M -$483K -9.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$20.8M -$6.09M -$1.03M -20.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$19.7M -$3.5M +$1.32M +27.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 -$21.1M -$6.15M -$1.64M -36.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$19.4M -$5.03M -$1.4M -38.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$18M -$5.06M -$491K -10.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$17.5M -$4.81M -$474K -10.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 -$17.1M -$4.51M -$1.92M -74% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$15.1M -$3.63M +$1.83M +33.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$17M -$4.57M -$1.93M -73.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$15M -$4.34M -$945K -27.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 -$14.1M -$2.59M -$187K -7.78% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$13.9M -$5.46M -$4.14M -313% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-16
Q1 2018 -$9.76M -$2.64M -$1.1M -71.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 -$8.65M -$3.39M -$1.98M -140% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q3 2017 -$6.68M -$2.4M -$982K -69.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$5.69M -$1.32M -$596K -82.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$5.1M -$1.54M -$1.21M -378% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$3.88M -$1.42M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-28
Q3 2016 -$1.42M -$1.2M -538% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$724K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 -$321K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q3 2015 -$223K Jul 28, 2015 Sep 30, 2015 10-Q 2016-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.